MedTrace Logo

Comparison of Two Treatment Regimens in Asthmatic Patients

NCT01488773 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2012-01-12

No results posted yet for this study

Summary

The objective of the study was to compare in real life clinical practice two treatment regimens: inhaled glucocorticosteroid + salmeterol and inhaled glucocorticosteroid + montelukast.

Conditions

Interventions

DRUG

first prescription of montelukast

The index event (intervention) was defined as the first prescription for montekuast (leukotriene receptor antagonist) occurring in patient's medical history that established a 12-month pre-index and three consecutive 12-month post-index periods.

DRUG

first prescription of salmeterol

The index event (intervention) was defined as the first prescription for salmeterol (long-acting β2-agonist) occurring in patient's medical history that established a 12-month pre-index and three consecutive 12-month post-index periods.

Sponsors & Collaborators

  • Medical University of Lodz

    lead OTHER

Principal Investigators

  • Rafal Pawliczak, MD PhD · Department of Immunopathology Chair of Allergy, Immunology and Dermatology Faculty of Biomedical Sciences and Postgraduate Training Medical University of Lodz

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-04-30
Primary Completion
2006-06-30
Completion
2006-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01488773 on ClinicalTrials.gov